On air · 2 of 3 networks
AGC Biologics
- agcbio.com
- Healthcare & Life Sciences
- US
- 2,504 employees
AGC Biologics’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 65. Watch AGC Biologics with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 1 | Checked 30 Oct 2026 | See all 65 ads → | ||
| Meta | None recorded | 0 | No active ads recorded on the Meta Ad Library | Checked 16 Oct 2026 | Collect them with the API → |
| Running | 28 | Ads on the Google Ads Transparency Center | Checked 30 Oct 2026 | Collect them with the API → |
AGC Biologics has 1 live LinkedIn ad. Its Facebook page had no active ads on 16 Oct 2026, and we recorded 28 Google ads on 30 Oct 2026.
Latest ads
- LINKEDIN · IMAGESince 1 Oct 2026
Struggling to produce stable complex proteins like bispecifics, trispecifics, and atypicals? Our whitepaper provides insights into how we leverage transposase technology to engineer cell lines that produce complex proteins with greater stability, consistency, and yields. 💪 Learn how a semi-targeted integration strategy can deliver a 10-fold increase of your complex protein ⬇️ https://lnkd.in/eQTRhe7q/?utm_campaign=Boost_Post_WebsiteVisits_Oct1,2026&utm_source=linkedin&utm_medium=paid&utm_id=1217175456&hsa_acc=510141467&hsa_cam=1217175456&hsa_grp=907776106&hsa_ad=1630995076&hsa_net=linkedin&hsa_ver=3 #CLD #transposases #ComplexProteins #yourfriendlyCDMOexpert
- LINKEDIN · CAROUSELSince 17 Sept 2026
Demand can shift. CMC data and regulatory needs can change your program’s trajectory fast. Your manufacturing strategy can flex right along with it. Scale-out production using single-use technology helps you reach IND quickly and allows you to adjust your manufacturing needs as clinical data comes in, while managing costs accordingly. Explore today.
- LINKEDIN · CAROUSELSince 17 Sept 2026
Not sure what demand for your biologic will look like a year from now? Three years from now? Utilizing a scale-out manufacturing strategy can help you plan and manage risk along the way as you prepare for clinical submissions, and beyond. Get the guide.
- LINKEDIN · IMAGESince 17 Sept 2026
Not sure what demand for your biologic will look like a year from now? Three years from now? Utilizing a scale-out manufacturing strategy can help you plan and manage risk along the way as you prepare for clinical submissions, and beyond. Get the guide.
- LINKEDIN · IMAGESince 17 Sept 2026
Demand can shift. CMC data and regulatory needs can change your program’s trajectory fast. Your manufacturing strategy can flex right along with it. Scale-out production using single-use technology helps you reach IND quickly and allows you to adjust your manufacturing needs as clinical data comes in, while managing costs accordingly. Explore today.
- LINKEDIN · IMAGESince 17 Sept 2026
Demand can shift. CMC data and regulatory needs can change your program’s trajectory fast. Your manufacturing strategy can flex right along with it. Scale-out production using single-use technology helps you reach IND quickly and allows you to adjust your manufacturing needs as clinical data comes in, while managing costs accordingly. Explore today.
6 of 65 adsSign up to see every AGC Biologics ad, filter by format and date, and get alerts on new ones.
See all 65 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.